Two major drug manufacturers this week sued Kansas in an effort to block the state’s new contract pharmacy access law, [...] …
Category: Judicial
News Alert
Federal Judge Denies Drugmakers’ Bids to Block Mississippi’s New 340B Contract Pharmacy Access Law
A federal district judge has rejected two drug industry attempts to block Mississippi’s new state law prohibiting drugmaker 340B contract [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A landmark Supreme Court decision to limit the broad regulatory authority of federal agencies will increase pressure for Congress to [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Groups representing Maryland providers along with national advocacy groups recently urged a federal judge to reject Novartis’ attempt to block [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Dozens of hospitals in Texas and other states have filed suits against Department of Health and Human Services (HHS) Secretary [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
The New York Times has sued the federal agency tasked with overseeing the 340B program to force the release of [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Two community health centers urged a federal appeals court to reverse an earlier dismissal of their lawsuit alleging four major [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A powerful brand-name drug industry trade organization has asked a federal district judge to block Maryland from enforcing the state’s [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A key argument in AstraZeneca’s lawsuit challenging Arkansas’ 340B contract pharmacy access law has already been rejected by a higher [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Drug manufacturer Novartis uses contradictory, “whiplash-inducing” arguments in its lawsuit challenging Mississippi’s 340B contract pharmacy law, hospital groups told a [...] …
